Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-06-10
著者
-
TAKAHASHI Toshitada
Division of Immunology, Aichi Cancer Center
-
Takahashi T
Division Of Immunology Aichi Cancer Center Research Institute
-
Takahashi Toshitada
愛知県がんセンター
-
Obata Yuichi
Division Of Immunology Aichi Cancer Center Research Institute
-
Obata Yuichi
Department Of Pathology Aichi Cancer Center
-
TSUJIMURA Kunio
Division of Immunology, Aichi Cancer Center Research Institute
-
Takahashi Toshitada
Division Of Immunology Aichi Cancer Center
-
Tsujimura K
Department Of Infectious Diseases Hamamatsu University School Of Medicine
-
Tsujimura Kunio
Division Of Immunology Aichi Cancer Center Research Institute
-
Obata Yuichi
Department Of Genetics And Pathology Aichi Cancer Center Hospital
-
TAKAHASHI Toshitada
Comprehensive Health Science Center
-
Takahashi Toshitada
Division Of Cancer Screening Research Center For Cancer Prevention And Screening National Cancer Cen
-
OBATA Yuichi
Department of Biological Systems, RIKEN BioResource Center, Tsukuba Institute, RIKEN
関連論文
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Localization of Gelatinolytic Activity Can Be Detected in Breast Cancer Tissues by Film in situ Zymography
- Limited association between a catechol-O-methyltransferase (CONT) polymorphism and breast cancer risk in Japan
- No Association of the 5' Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan
- Identification of Cancer Antigens in Breast Cancer by the SEREX Expression Cloning Method
- Novel Functions of Herbal Medicines in Dendritic Cells : Role of Amomi Semen in Tumor Immunity
- CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
- Epstein-Barr virus nuclear antigen 1-specific CD4^+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
- Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells : application for allogeneic transplantation
- Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
- Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea
- Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen
- Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the α1/α2 domain of TL free from antigenic peptides
- Comparison of Anti-Tumor Responses against TL Positive Lymphoma Induced by Skin Grafting and Dendritic Cell Immunization
- Murine Delta Homologue, mDelta1, Expressed on Feeder Cells Controls Cellular Differentiation
- The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent
- NF-κB is required for CD38-mediated induction of C_γ1 germline transcripts in murine B lymphocytes
- Recombinant Cholera Toxin B Subunit Activates Dendritic Cells and Enhances Antitumor Immunity
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation